To the top

Page Manager: Webmaster
Last update: 9/11/2012 3:13 PM

Tell a friend about this page
Print version

Renal function affects ab… - University of Gothenburg, Sweden Till startsida
To content Read more about how we use cookies on

Renal function affects absorbed dose to the kidneys and haematological toxicity during (177)Lu-DOTATATE treatment.

Journal article
Authors Johanna Svensson
Gertrud Berg
Bo Wängberg
Maria Larsson
Eva Forssell-Aronsson
Peter Bernhardt
Published in European journal of nuclear medicine and molecular imaging
Volume 42
Issue 6
Pages 947-955
ISSN 1619-7089
Publication year 2015
Published at Institute of Clinical Sciences, Department of Radiation Physics
Pages 947-955
Language en
Keywords Lu-177-DOTATATE therapy, PRRT, Neuroendocrine tumours, Dosimetry
Subject categories Diagnostic radiology, Kidney diseases


Peptide receptor radionuclide therapy (PRRT) has become an important treatment option in the management of advanced neuroendocrine tumours. Long-lasting responses are reported for a majority of treated patients, with good tolerability and a favourable impact on quality of life. The treatment is usually limited by the cumulative absorbed dose to the kidneys, where the radiopharmaceutical is reabsorbed and retained, or by evident haematological toxicity. The aim of this study was to evaluate how renal function affects (1) absorbed dose to the kidneys, and (2) the development of haematological toxicity during PRRT treatment.

Page Manager: Webmaster|Last update: 9/11/2012

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?